Test Price
2,800 AED✅ Home Collection Available
UPB1 Gene Beta‑Ureidopropionase Deficiency Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Clinical Certainty, Delivered with UAE Precision
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited next‑generation sequencing processing.
- Premium Logistics: Hospital‑grade home collection with ISO‑certified cold‑chain transport, available 8 AM – 11 PM daily.
- Clinical Guidance: Post‑test telephonic consultation with a Consultant Medical Geneticist to interpret results within your complete clinical context.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The UPB1 Genetic Test screens the entire coding region and adjacent splice sites of the beta‑ureidopropionase gene, detecting pathogenic variants responsible for this inborn error of pyrimidine metabolism. High‑coverage next‑generation sequencing (NGS) enables comprehensive analysis supporting early diagnosis and personalised management for affected individuals and at‑risk family members. Every result is correlated with detailed clinical and biochemical findings by a board‑certified medical geneticist.
| Feature | Our NGS Test (UPB1) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity | ~99.0% (limited to known hotspots) |
| Methodology | Next‑Generation Sequencing (NGS) | Capillary Electrophoresis (targeted) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Coverage | Entire coding region ± splice sites | Selected exons only |
| Price | 2800 AED | ~3200–3800 AED |
Physician Insight & Safety Protocols
“The UPB1 genetic test offers a definitive molecular window into beta‑ureidopropionase deficiency, yet every result must be interpreted alongside detailed clinical and biochemical parameters. As a Consultant Medical Geneticist, I emphasise that outcome discussion with a metabolic specialist is essential for guiding lifelong management, dietary interventions, and family risk assessment. No single laboratory value replaces the full picture of a patient’s health.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Pre-Test Advisory & Patient Safety
- Medication Continuation: Do not discontinue any prescribed therapy without explicit approval from your treating physician. This genetic test does not replace therapeutic decision‑making.
- Emergency Recognition: If you experience acute neurological deterioration (seizures, severe hypotonia, or loss of consciousness) following the blood draw, seek emergency care immediately. Such events are extremely rare and not directly related to the test itself.
Exclusion Criteria & Consent Requirements
- Genetic Counselling Prerequisite: Testing without prior genetic counselling is not recommended. Patients with no family history or clinical suspicion of metabolic disease should consult a specialist first.
- Minor Consent: Testing of individuals under 18 years requires documented guardian consent in accordance with UAE regulatory frameworks and clinical genetics guidelines.
Patient FAQ & Clinical Guidance
1. What exactly does the UPB1 genetic test detect?
The UPB1 NGS test precisely identifies disease‑causing mutations in the beta‑ureidopropionase enzyme gene. It screens all coding exons and adjacent splice regions using high‑coverage next‑generation sequencing, delivering a comprehensive genetic profile for beta‑ureidopropionase deficiency — a rare but treatable inborn error of pyrimidine catabolism. Results are correlated with biochemical phenotype to confirm diagnosis.
2. How long until I receive my results?
Standard turnaround time for UPB1 genetic analysis is three to four weeks. The timeline accounts for high‑coverage sequencing, bioinformatic processing, and dual‑clinician verification to guarantee the highest accuracy before the report is released through our secure patient portal. Urgent clinical cases may be expedited upon request.
3. Can a nurse come to my home for the blood draw?
Yes — our team offers VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection from 8 AM to 11 PM daily, covering all Emirates. The service utilises hospital‑grade phlebotomy kits and ISO‑certified logistics. A peripheral whole blood sample is collected for DNA extraction; schedule via WhatsApp +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic information is processed and stored in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your genomic data is encrypted, access‑controlled, and used solely for diagnostic purposes with your explicit written consent. DNA Labs UAE holds DHA Facility License No. 1143 and operates under ISO 9001:2015 quality management standards.
Clinical & Logistical Metadata
| Test Name | UPB1 Gene Beta‑Ureidopropionase Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (21–28 calendar days) |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene coverage including coding exons and splice junctions |
| ICD-10-CM Code | E79.89 |
| LOINC Code | 82324-2 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians